they mean business

14 Houston energy companies power up Fortune Global 500 list

Aramco is the world's fourth biggest company.

Courtesy of Aramco

Fourteen businesses with global or regional headquarters in the Houston area appear on Fortune’s new list of the world’s 500 biggest companies.

Oil and gas company Saudi Aramco, whose headquarters for the Americas is in Houston, leads the Houston-area pack. With annual revenue of $494.9 billion, it lands at No. 4 on the Fortune Global 500. Ahead of Saudi Aramco are U.S. retailers Walmart and Amazon, and Chinese electric company State Grid.

To put Saudi Aramco’s annual revenue in perspective, the total is slightly above the gross domestic product for the Philippines.

For the third year in a row, Saudi Aramco stands out as the most profitable member of the Fortune Global 500. The company racked up $121 billion in profit last year.

Overall, Saudi Aramco and 32 other petroleum refiners — many of them with a significant presence in the Houston area — made the Fortune Global 500.

“The Global 500 is the ultimate scorecard for business success. The aggregate revenue of the Fortune Global 500 in 2023 reached $41 trillion, a record level. That sum represents more than a third of global GDP — a sign of how much economic power is concentrated in these companies,” Scott DeCarlo, Fortune’s vice president of research, says in a news release.

Here’s the rundown of Fortune Global 500 companies with global or regional headquarters in the Houston area, including the ranking and annual revenue for each:

Saudi Aramco, No. 4, $494.9 billion, Americas headquarters in Houston
ExxonMobil, No. 12, $344.6 billion, global headquarters in Spring
Shell, No. 13, $323.2 billion; U.S. headquarters in Houston
TotalEnergies, No. 23, $218.9 billion, U.S. headquarters in Houston
BP, No. 25, $213 billion, U.S. headquarters in Houston
Chevron, No. 29, $200.9 billion, global headquarters relocating to Houston in 2024
Phillips 66, No. 52, $149.9 billion, global headquarters in Houston
Engie, No. 130, $89.3 billion, North American headquarters in Houston
Sysco, No. 163, $76.3 billion, global headquarters in Houston
ConocoPhillips, No. 235, $58.6 billion, global headquarters in Houston
Enterprise Products Partners, No. 303, $49.7 billion, global headquarters in Houston
Plains GP Holdings, No. 311, $48.7 billion, global headquarters in Houston
LyondellBasell, No. 368, $41.1 billion, global headquarters in Houston
SLB (formerly Schlumberger), No. 479, $33.1 billion, global headquarters in Houston

Fortune uses revenue figures for budget years ending on or before March 31, 2024, to rank the world’s largest companies.

---

This story originally appeared on our sister site EnergyCapitalHTX.

business media lists

a major award

$2.6 million grant funds UH research towards a fentanyl vaccine

Photo by Jellybee on Unsplash

UH has received a new financial gift towards the Michael C. Gibson Addiction Research Program, which is developing a fentanyl vaccine.

The estate of Dr. William A. Gibson has granted the University of Houston a $2.6 million gift to support and expand its opioid addiction research, including the development of a fentanyl vaccine that could block the drug's ability to enter the brain.

The gift builds upon a previous donation from the Gibson estate that honored the scientist’s late son Michael, who died from drug addiction in 2019. The original donation established the Michael C. Gibson Addiction Research Program in UH's department of psychology. The latest donation will establish the Michael Conner Gibson Endowed Professorship in Psychology and the Michael Conner Gibson Research Endowment in the College of Liberal Arts and Social Sciences.

“This incredibly generous gift will accelerate UH’s addiction research program and advance new approaches to treatment,” Daniel O’Connor, dean of the College of Liberal Arts and Social Sciences, said in a news release.

The Michael C. Gibson Addiction Research Program is led by UH professor of psychology Therese Kosten and Colin Haile, a founding member of the UH Drug Discovery Institute. Currently, the program produces high-profile drug research, including the fentanyl vaccine.

According to UH, the vaccine can eliminate the drug’s “high” and could have major implications for the nation’s opioid epidemic, as research reveals Opioid Use Disorder (OUD) is treatable.

The endowed professorship is combined with a one-to-one match from the Aspire Fund Challenge, a $50 million grant program established in 2019 by an anonymous donor. UH says the program has helped the university increase its number of endowed chairs and professorships, including this new position in the department of psychology.

“Our future discoveries will forever honor the memory of Michael Conner Gibson and the Gibson family,” O’Connor added in the release. “And I expect that the work supported by these endowments will eventually save many thousands of lives.”

----

This story originally was published on our sister site, InnovationMap.

research university of houston

they mean business

14 Houston energy companies power up Fortune Global 500 list

a major award

$2.6 million grant funds UH research towards a fentanyl vaccine

Family-friendly Houston restaurant picks Missouri City for 6th location

$150 million, 12,500-seat entertainment venue coming to Houston in 2027

Beyoncé-loved Houston brunch spot expands and more popular stories